Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Turn Bio adds veteran executives with decades of international business development, intellectual property expertise 2022-03-07 20:00
TCI Enters into Strategic Alliance with VeCollal(R) and CDMO the World's First, Science-based vegan collagen alternative 2022-03-07 16:00
Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect 2022-03-07 15:57
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs 2022-03-07 09:00
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer 2022-03-07 09:00
Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy 2022-03-04 21:00
Genome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients 2022-03-04 09:30
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers 2022-03-04 08:00
Claudin18.2 CAR T Cells (CT041) Receives Approval to Initiate A Confirmatory Phase II Clinical Trial for advanced GC/GEJ in China 2022-03-03 21:50
CNN's Vital Signs explores the future of medicine 2022-03-03 10:13
Akeso Announces Clinical Trial Collaboration with Chipscreen Biosciences to Evaluate Cadonilimab in Combination with Chiauranib for Extensive-Stage Small-Cell Lung Cancer 2022-03-03 01:34
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 2022-03-02 20:00
Four new leaders join Cargill's executive team, aligned to company's innovation strategy and customer priorities 2022-03-02 14:16
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China 2022-03-02 10:37
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications 2022-03-02 08:47
Cambrex Expands Biopharmaceutical Services Business 2022-03-01 22:00
Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US 2022-03-01 20:30
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Eight Additional European Countries 2022-03-01 17:30
Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data 2022-03-01 14:00
1 189 190 191 192 193 452